Publicacions (34) Publicacions en què ha participat algun/a investigador/a

2005

  1. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice

    Neurobiology of Disease, Vol. 20, Núm. 3, pp. 814-822

  2. Amplification of IGH/MYC fusion in clinically aggressive IGH/BCL2-positive germinal center B-cell lymphomas

    Genes Chromosomes and Cancer, Vol. 43, Núm. 4, pp. 414-423

  3. Analysis of myelodysplastic syndromes with complex karyotypes by high-resolution comparative genomic hybridization and subtelomeric CGH array

    Genes Chromosomes and Cancer, Vol. 42, Núm. 3, pp. 287-298

  4. Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis: Results from the Dallas Heart Study

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 25, Núm. 10, pp. 2192-2196

  5. Coexistence of different clonal populations harboring the b3a2 (p210) and e1a2 (p190) BCR-ABL1 fusion transcripts in chronic myelogenous leukemia resistant to imatinib

    Cancer Genetics and Cytogenetics, Vol. 160, Núm. 1, pp. 22-26

  6. Disruption and aberrant expression of HMGA2 as a consequence of diverse chromosomal translocations in myeloid malignancies

    Leukemia, Vol. 19, Núm. 2, pp. 245-252

  7. Elevated release of sCD40L from platelets of diabetic patients by thrombin, glucose and advanced glycation end products

    Diabetes and Vascular Disease Research, Vol. 2, Núm. 2, pp. 81-87

  8. Erratum: NUP98 is fused to HOXA9 in a variant complex t(7;11;13;17) in a patient with AML-M2 (Cancer Genetics and Cytogenetics (2005) 157 (151-6))

    Cancer Genetics and Cytogenetics

  9. Estrés oxidativo y patología vascular

    Endotelio vascular y estatinas (Línea de Comunicación), pp. 29-45

  10. FISH analysis of hematological neoplasias with 1p36 rearrangements allows the definition of a cluster of 2.5 Mb included in the minimal region deleted in 1p36 deletion syndrome

    Human Genetics, Vol. 116, Núm. 6, pp. 476-485

  11. Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32)

    Blood, Vol. 105, Núm. 12, pp. 4849-4852

  12. Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes

    Haematologica, Vol. 90, Núm. 9, pp. 1168-1178

  13. Increased phagocytic nicotinamide adenine dinucleotide phosphate oxidase-dependent superoxide production in patients with early chronic kidney disease

    Kidney International

  14. Indoleamine 2,3-dioxygenase: From tolerance during pregnancy to cancer

    Inmunologia, Vol. 24, Núm. 4, pp. 20-27

  15. Inhibition of phosphorolysis catalyzed by HIV-1 reverse transcriptase is responsible for the synergy found in combinations of 3′-azido-3′- deoxythymidine with nonnucleoside inhibitors

    Biochemistry, Vol. 44, Núm. 9, pp. 3535-3546

  16. Intralaminar thalamic nuclei are main regulators of basal ganglia - Possible involvement in the pathophysiology of Parkinson's disease

    Basal Ganglia VIII

  17. Is plasma cardiotrophin-1 a marker of hypertensive heart disease?

    Journal of Hypertension, Vol. 23, Núm. 3, pp. 625-632

  18. Lack of association of CYP3A4-V polymorphism with the risk of treatment-related leukemia

    Leukemia Research

  19. Linking two immuno-suppressive molecules: Indoleamine 2,3 dioxygenase can modify HLA-G cell-surface expression

    Biology of Reproduction, Vol. 73, Núm. 3, pp. 571-578

  20. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer

    Nature Genetics, Vol. 37, Núm. 4, pp. 391-400